DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens
DreaMed Diabetes has received FDA 510(K) clearance for MODI, a tool that uses continuous glucose monitoring data to provide insulin dosing recommendations for people with Type 2 diabetes who need…